Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
676
Catenins01:23

Catenins

3.0K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.0K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

790
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
790
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.1K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A modular neural circuit for computing the motion of objects.

bioRxiv : the preprint server for biology·2026
Same author

Comment on a recent policy change by the American Veterinary Medical Association's House of Delegates regarding pain management and declawing.

The Journal of small animal practice·2026
Same author

Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein.

Journal of veterinary pharmacology and therapeutics·2023
Same author

Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation.

Journal of veterinary pharmacology and therapeutics·2022
Same author

Investigating the pathogenesis of high-serum gamma-glutamyl transferase activity in Thoroughbred racehorses: A series of case-control studies.

Equine veterinary journal·2021
Same author

The effect of cannabidiol on canine neoplastic cell proliferation and mitogen-activated protein kinase activation during autophagy and apoptosis.

Veterinary and comparative oncology·2020

Related Experiment Video

Updated: Jan 17, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.9K

Cats and cannabinoids: past, present and future.

Stephen Niño Cital1,2, Joseph Wakshlag3, Amanda Kennedy4

  • 1Department of Neurobiology, Howard Hughes Medical Institute at Stanford University, Stanford, CA, USA.

Journal of Feline Medicine and Surgery
|September 19, 2025
PubMed
Summary

Cannabidiol (CBD) shows emerging clinical utility in veterinary medicine, particularly for dogs. While research on cats is limited, favorable pharmacokinetics suggest potential for future feline studies in pain and anxiety.

Keywords:
CBDCBDACannabidiolbioavailabilitycannabidiolic acidendocannabinoid systempharmacokinetics

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

805
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

377

Related Experiment Videos

Last Updated: Jan 17, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.9K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

805
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

377

Area of Science:

  • Veterinary Pharmacology
  • Cannabinoid Therapeutics
  • Animal Health Research

Background:

  • Hemp-derived cannabinoids, including cannabidiol (CBD), are increasingly used in veterinary medicine.
  • Owner inquiries focus on conditions like osteoarthritis, behavioral issues, cancer, dermatitis, and seizures.
  • Existing evidence for cannabinoid efficacy is growing for dogs but remains limited for cats.

Purpose of the Study:

  • To review the current state of cannabinoid (CBD) research in veterinary medicine, with a focus on cats.
  • To highlight emerging pharmacokinetic data and clinical evidence for CBD in feline applications.
  • To identify gaps in knowledge and suggest future research directions for feline cannabinoid therapy.

Main Methods:

  • Review of recent publications on feline cannabinoid pharmacokinetics, bioavailability, and clinical studies.
  • Analysis of pre-clinical data with potential for clinical translation in feline conditions.
  • Consideration of anecdotal evidence from owners and veterinary practitioners.

Main Results:

  • Feline pharmacokinetics of CBD and cannabidiolic acid show significant variability in bioavailability.
  • Formulation differences impact serum/plasma concentrations in cats.
  • Limited clinical studies exist for feline pain, anxiety, and stress, alongside promising pre-clinical findings.

Conclusions:

  • Favorable pharmacokinetics in cats suggest potential for CBD use, but clinical evidence is scarce.
  • Further pilot investigations are needed to optimize dosing and product selection for cats.
  • Future randomized, placebo-controlled studies are essential to establish efficacy across various feline morbidities.